Hematology and Oncology
Home Hematology and Oncology
Delay in Tranexamic Acid Administration Reduces Benefit
Survival benefit decreases by 10 percent for every 15-minute delay in treatment for severe bleeding
ASCO Issues Statement Regarding Alcohol and Cancer
Alcohol-related cancers account for 5.5 percent of all cancers treated annually worldwide
Zelboraf Approved for Use in Erdheim-Chester Disease
Kinase inhibitor (vemurafenib) for use in patients with BRAF V600 mutation
Doctors Have Extra Two Weeks to Preview Performance Data
Due to technical issue with Physician Compare, CMS extending time frame for physicians to view data
Legal Aspects to Consider in Voluntary Refusal to Eat, Drink
Patients, families, clinicians must consider clinical, ethical, legal aspects of VSED to hasten death
Intensity of Exercise Affects Impact on Mortality Risk
Findings support recommendation of moderate- to vigorous-intensity physical activity
Warfarin Use Linked to Reduced Incidence of Cancer
Reduced incidence rate ratio in all cancer sites and in prevalent cancer sites among adults aged >50
Cannabidiol Concentration Varies Widely in Online Products
Of 84 products sampled, 42.85 percent were underlabeled and 26.19 percent were overlabeled
Incidence of Early-Stage Breast CA, CRC Up With ACA Adoption
No change in incidence of locally advanced or metastatic-stage cancer after ACA adoption
Facility Volume Found to Impact Nasopharyngeal CA Survival
Treatment at high-volume facility independently predicts higher overall survival in multivariate model
